BEI
BIO icon

Benjamin Edwards Inc’s Bio-Rad Laboratories Class A BIO Stock Holding History

Benjamin Edwards Inc’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Buy
1,643
+261
+19% +$74K ﹤0.01% 1075
2026
Q1 		$385K Buy
1,382
+379
+38% +$109K ﹤0.01% 1080
2025
Q4 		$304K Buy
1,003
+245
+32% +$76.5K ﹤0.01% 1106
2025
Q3 		$212K Buy
+758
New +$206K ﹤0.01% 1231
2022
Q1 		– Sell
-18
Closed -$14K – 697
2021
Q4 		$14K Buy
18
+14
+350% +$10.5K ﹤0.01% 550
2021
Q3 		$3K Buy
+4
New +$3K ﹤0.01% 496

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Benjamin Edwards Inc's BIO Position: Q2 2026 in Review

Benjamin Edwards Inc increased its Bio-Rad Laboratories Class A (BIO) stake by 19% in Q2 2026, buying an estimated $74K and bringing the position to 1,643 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #1075.

Benjamin Edwards Inc first reported a position in BIO in Q3 2021 and has held it in 6 quarters since. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Benjamin Edwards Inc held 1,643 shares of Bio-Rad Laboratories Class A worth $482K as of Q2 2026.
  • Benjamin Edwards Inc bought 261 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $74K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #1075 holding.
  • Benjamin Edwards Inc first reported a position in Bio-Rad Laboratories Class A in Q3 2021 and has held it in 6 quarters since.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.